Recce Pharmaceuticals Announces Positive Safety Data from Third Cohort of Phase I Clinical Trial Evaluating Healthy Subjects Intravenously Dosed with RECCE® 327
Highlights: Seven subjects in cohort three intravenously dosed; RECCE® 327 at 500mg indicating to be…
Fuentes Zapata LLC Announces the Release of “The Remote Marketer’s Toolkit”
Sheds For Less Direct Celebrates 20 Years as America’s Original Nationwide Shed Dealer
NightCafe Studio Leverages Google Cloud to Power AI Art Creation for 25 Million Users with a Four-Person Team
TEN Framework Celebrates One-Year Anniversary as Open-Source Infrastructure for Real-Time Conversational AI Development
Safety Training Seminars Opens New CPR Certification School in San Mateo, CA